Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46,691,176
-
Total 13F shares
-
16,170,891
-
Share change
-
+1,065,400
-
Total reported value
-
$389,389,000
-
Price per share
-
$24.08
-
Number of holders
-
52
-
Value change
-
-$3,186,320
-
Number of buys
-
38
-
Number of sells
-
29
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q2 2021
As of 30 Jun 2021 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,170,891 shares of stock of the company.
Largest 10 holders included VIKING GLOBAL INVESTORS LP, BVF INC/IL, JANUS HENDERSON GROUP PLC, Casdin Capital, LLC, FMR LLC, ArrowMark Colorado Holdings LLC, Aquilo Capital Management, LLC, Octagon Capital Advisors LP, BlackRock Inc., and ALKEON CAPITAL MANAGEMENT LLC.
This table shows 52 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.